April 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJuly 24, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreApril 21, 2026
Based on market forecasts, the primary cell culture sector will expand from USD 6.61 billion in 2024 to USD 20.62 billion by 2034, experiencing a CAGR of 12.05%. The growing prevalence of various chronic conditions is driving the market’s growth....
April 21, 2026
According to market projections, the global stem cells market, valued at USD 16.63 billion in 2024, is anticipated to reach USD 49.26 billion by 2034, growing at a CAGR of 11.47% over the next decade. Growing research and development in different stem cells for therapeutic purposes is driving the market’s growth....
April 21, 2026
According to market projections, the global rat and mouse model market, valued at USD 1.56 billion in 2024, is anticipated to reach USD 3.10 billion by 2034, growing at a CAGR of 7.10% over the next decade. Growing research and development in different pharmaceutical and healthcare sectors drives market growth....
April 21, 2026
According to market estimations the in vitro lung model market to rise from $432.76 million in 2025 to $943.61 million by 2030. North America, having dominated the market with a 45.1% share in 2023, will continue to be a key player, while the pharmaceutical and biotechnology companies segment remains dominant in terms of end-use....
April 21, 2026
According to market projections, the global multiplex detection immunoassay market, valued at USD 2.82 billion in 2024, is anticipated to reach USD 7.81 billion by 2034, growing at a CAGR of 9.75% over the next decade. The increasing research in genomics, proteomics, biopharmaceuticals, and clinical diagnostics drives the market....
April 21, 2026
Cervical cancer is caused by HPV infections and diagnosed through tests like Pap tests, HPV tests, biopsies, and imaging. Regular screenings and advancements in diagnostic techniques are driving market growth. Initiatives like the WHO’s Global Strategy and investments, such as DNA Wellness' 100 labs, are boosting awareness and detection effor...
April 21, 2026
The medical imaging reagents market includes various agents used in diagnostic techniques like MRI, X-ray, and PET. These reagents help in detecting diseases, monitoring cellular functions, and improving early diagnosis. Companies like Siemens Healthineers and GE Healthcare are advancing imaging technologies, with AI enhancing accuracy and efficien...
April 21, 2026
Organ-on-a-chip (OoC) systems use tiny tissues in microfluidic chips to mimic human physiology. By improving drug development, accuracy, and cost efficiency, OoCs offer a more precise alternative to animal models. The FDA’s 2022 act supports using non-animal data for clinical trials, advancing research....
April 21, 2026
According to market projections, the glycomics sector is expected to grow from USD 2.21 billion in 2024 to USD 8.66 billion by 2034, reflecting a CAGR of 14.64%. The glycomics field is growing significantly due to its applications in drug discovery, disease diagnosis, therapeutics, and personalized medicine....
April 21, 2026
Market insights predict the global stroke management industry will increase from USD 44.82 billion in 2025 to USD 91.86 billion by 2035, achieving a CAGR of 7.44%. The stroke management market is growing rapidly, driven by advancements in emergency treatments for ischemic and hemorrhagic strokes. Innovations like argatroban improve outcomes, while ...